Cart
sales@molnova.com
Abelacimab
CAS No. 2098724-83-3
Abelacimab( —— )
Catalog No. M36766 CAS No. 2098724-83-3
Abelacimab (MAA868), a fully human IgG1 monoclonal antibody, targets and binds with high affinity to FXI's catalytic structural domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 593 | Get Quote |
|
| 5MG | 945 | Get Quote |
|
| 10MG | 1520 | Get Quote |
|
| 25MG | 2475 | Get Quote |
|
| 50MG | 3662 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAbelacimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbelacimab (MAA868), a fully human IgG1 monoclonal antibody, targets and binds with high affinity to FXI's catalytic structural domain.
-
DescriptionAbelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2098724-83-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alexander W Koch, et al. MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans. Blood. 2019 Mar 28;133(13):1507-1516.?
molnova catalog
related products
-
Fasoracetam
Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
-
7-Methyladenine
7-Methyladenine can be used as a marker of exposure to exogenous and carcinogenic methylating agents.
-
Chondroitin sulfate ...
Chondroitin sulfate sodium, a class of glycosaminoglyphans, is extensively utilized in managing osteoarthritis.
